Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice
Frontiers in Psychiatry May 25, 2022 Kevin Mintz, Brinn Gammer, Amanda Khan et al. 13 citations
Clinical trials for psychedelic therapies have increased but often exclude individuals with physical and sensory disabilities, risking structural ableism. Drawing on disability studies and medical ethics, the authors recommend prioritizing inclusion, providing accommodations, training facilitators in disability awareness, and practicing cultural humility. These steps aim to address mental health burdens faced by disability communities and spur further debate on accessibility.